FNCMX
Price
$291.42
Change
-$6.82 (-2.29%)
Updated
Nov 13 closing price
Net Assets
23.65B
GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

FNCMX vs GFACX

Header iconFNCMX vs GFACX Comparison
Open Charts FNCMX vs GFACXBanner chart's image
Fidelity Nasdaq Composite Index
Price$291.42
Change-$6.82 (-2.29%)
VolumeN/A
Net Assets23.65B
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
FNCMX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
FNCMX vs. GFACX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNCMX is a Hold and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. FNCMX (23.6B). FNCMX pays higher dividends than GFACX: FNCMX (0.49) vs GFACX (0.00). FNCMX was incepted earlier than GFACX: FNCMX (22 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than FNCMX (0.30). GFACX is a more actively managed with annual turnover of: 25.00 vs. FNCMX (2.00). FNCMX has a lower initial minimum investment than GFACX: FNCMX (0) vs GFACX (250). FNCMX annual gain was more profitable for investors over the last year : 22.47 vs. GFACX (4.61). FNCMX return over 5 years is better than : 106.16 vs. GFACX (27.87).
FNCMXGFACXFNCMX / GFACX
Total Expense Ratio0.291.3621%
Annual Report Gross Expense Ratio0.301.3622%
Fund Existence22 years25 years-
Gain YTD21.84516.343134%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets23.6B340B7%
Annual Yield % from dividends0.490.00-
Returns for 1 year22.474.61487%
Returns for 3 years114.2556.17203%
Returns for 5 years106.1627.87381%
Returns for 10 years366.4475.78484%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics